AJP - GI Watch the video to learn how APS reaches out to developing nations.
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Gastrointest Liver Physiol 292: G590-G598, 2007. First published October 26, 2006; doi:10.1152/ajpgi.00252.2006 Free Article
0193-1857/07 $8.00
This Article
Free upon publication Free Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
292/2/G590    most recent
00252.2006v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (11)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Boivin, M. A.
Right arrow Articles by Ma, T. Y.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Boivin, M. A.
Right arrow Articles by Ma, T. Y.

INFLAMMATION/IMMUNITY/MEDIATORS

Mechanism of glucocorticoid regulation of the intestinal tight junction barrier

Michel A. Boivin,1 Dongmei Ye,1 John C. Kennedy,1 Rana Al-Sadi,1 Chris Shepela,1 and Thomas Y. Ma1,2

1Department of Medicine, University of New Mexico School of Medicine, and 2Albuquerque Veterans Affairs Medical Center, Albuquerque, New Mexico

Submitted 8 June 2006 ; accepted in final form 19 October 2006

A defective intestinal epithelial tight junction (TJ) barrier has been proposed as an important pathogenic factor contributing to the intestinal inflammation of Crohn's disease. Glucocorticoids are first-line therapeutic agents for the treatment of moderate to severe Crohn's disease. Glucocorticoid treatment has been shown to induce retightening of the intestinal TJ barrier defect in Crohn's disease patients. However, the mechanisms that mediate the glucocorticoid therapeutic action on intestinal TJ barrier function remain unknown. The aim of this study was to elucidate the mechanism of glucocorticoid modulation of the intestinal epithelial TJ barrier using an in vitro model system. Filter-grown Caco-2 intestinal epithelial cells were used as an in vitro model to examine the effects of glucocorticoids on basal intestinal epithelial TJ barrier function and on TNF-{alpha}-induced disruption of the TJ barrier. Glucocorticoids (prednisolone and dexamethasone) did not have a significant effect on baseline Caco-2 TJ barrier function but prevented the TNF-{alpha}-induced increase in Caco-2 TJ permeability. The glucocorticoid protective effect against the TNF-{alpha}-induced increase in Caco-2 TJ permeability required activation of the glucocorticoid receptor (GR) complex. The activation of the GR complex resulted in GR complex binding to the glucocorticoid response element (GRE) site on DNA and activation of a GR-responsive promoter. Glucocorticoids inhibited the TNF-{alpha}-induced increase in myosin light chain kinase (MLCK) protein expression, a key process mediating the TNF-{alpha} increase in intestinal TJ permeability. The glucocorticoid inhibition of the TNF-{alpha}-induced increase in MLCK protein expression was due to the binding of the GR complex to a GRE binding site on the MLCK promoter region suppressing the TNF-{alpha}-induced activation. Glucocorticoids inhibit the TNF-{alpha}-induced increase in Caco-2 TJ permeability. The prednisolone protective action was mediated by binding of activated GR complex to the GRE site on the MLCK promoter, suppressing the TNF-{alpha}-induced increase in MLCK gene activity, protein expression, and subsequent opening of the intestinal TJ barrier.

prednisolone; inflammation; tumor necrosis factor-{alpha}; glucocorticoid receptor; glucocorticoid response element; Crohn's disease



Address for reprint requests and other correspondence: T. Y. Ma, MSC 10 5550, Univ. of New Mexico, Albuquerque, NM 87131 (e-mail: tma{at}salud.unm.edu)




This article has been cited by other articles:


Home page
FASEB J.Home page
A. G. Atanasov, D. Leiser, C. Roesselet, M. Noti, N. Corazza, K. Schoonjans, and T. Brunner
Cell cycle-dependent regulation of extra-adrenal glucocorticoid synthesis in murine intestinal epithelial cells
FASEB J, December 1, 2008; 22(12): 4117 - 4125.
[Abstract] [Full Text] [PDF]


Home page
J. Physiol.Home page
V. Douard, H.-I. Choi, S. Elshenawy, D. Lagunoff, and R. P. Ferraris
Developmental reprogramming of rat GLUT5 requires glucocorticoid receptor translocation to the nucleus
J. Physiol., August 1, 2008; 586(15): 3657 - 3673.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online
Copyright © 2007 by the American Physiological Society.